More intriguingly, DCA attenuated the effects of cisplatin on ALDH+CD44+ cancer cells, consistent with previous findings that a dual DCA–platinum drug combination could effectively overcome resistance to cisplatin in ovarian cancer.50 The gene discussed is CD44; the disease is cancer.